Physician profile
Eric Malz
NPI 1598795536
$722.16
in general payments reported to CMS, 2019-2025
10 companies · $41.44 in 2025
The $41.44 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $504 · 2024: $51.78 · 2025: $41.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $170.35 | 2023 | Austedo Xr |
| Alkermes, INC. | $125.91 | 2023 | Lybalvi, Vivitrol |
| Abbvie INC. | $125.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $94.24 | 2023 | Spravato |
| Otsuka America Pharmaceutical, INC. | $71.44 | 2023 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $55.87 | 2023-2024 | Ingrezza |
| Vanda Pharmaceuticals INC. | $22.53 | 2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $19.77 | 2023 | Trintellix |
| Exact Sciences Corporation | $18.91 | 2025 | Cologuard Collection Kit |
| Acadia Pharmaceuticals INC | $18.14 | 2024 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Malz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.